Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Hyperliquid Strategies Inc (PURR : NSDQ)

• Company Description    Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. Hyperliquid Strategies Inc, formerly known as Sonnet BioTherapeutics Holdings Inc., is based in NEW YORK. Number of Employees: 9

• Price / Volume Information    Yesterday's Closing Price: $6.19 Daily Weekly Monthly 20 Day Moving Average: 10,549,831 shares Shares Outstanding: 144.45 (millions) Market Capitalization: $894.13 (millions) Beta: 1.66 52 Week High: $11.62 52 Week Low: $3.01 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -22.82% -23.39% 12 Week 2.82% 0.01% Year To Date 73.88% 68.97%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 477 MADISON AVENUE 22ND FLOOR - NEW YORK,NY 10022 USA ph: 212-883-4330 fax: 704-366-2463 sonn@jtcir.com http://www.sonnetbio.com

• General Corporate Information    Officers Raghu Rao - Chief Executive Officer and Director Donald Griffith - Chief Financial Officer and Director Albert Dyrness - Director Nailesh Bhatt - Director Donald Griffith - Director Peer Information Hyperliquid Strategies Inc (EIIN) Hyperliquid Strategies Inc (AFMI) Hyperliquid Strategies Inc (DRL) Hyperliquid Strategies Inc (GRFPY) Hyperliquid Strategies Inc (IGOT) Hyperliquid Strategies Inc (ATLC) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: FIN-MISC SVCS Sector: Finance CUSIP: 44916Y106 SIC: 6199 Fiscal Year Fiscal Year End: September Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/12/26 Share - Related Items Shares Outstanding: 144.45 Most Recent Split Date: 9.00 (0.13:1) Beta: 1.66 Market Capitalization: $894.13 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $2.10 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/12/26

• Fundamental Ratios P/E Current FY Estimate: 2.95 Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 1.03 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 213.48% vs. Previous Quarter: 113.59% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: 425.20% ROE 06/30/26 - - 03/31/26 - -56.04 12/31/25 - -211.32 ROA 06/30/26 - - 03/31/26 - -52.22 12/31/25 - -199.77 Current Ratio 06/30/26 - - 03/31/26 - 18.23 12/31/25 - 31.62 Quick Ratio 06/30/26 - - 03/31/26 - 18.22 12/31/25 - 31.62 Operating Margin 06/30/26 - - 03/31/26 - - 12/31/25 - - Net Margin 06/30/26 - - 03/31/26 - - 12/31/25 - - Pre-Tax Margin 06/30/26 - - 03/31/26 - -3,224.19 12/31/25 - -59,891.80 Book Value 06/30/26 - - 03/31/26 - 5.99 12/31/25 - 4.64 Inventory Turnover 06/30/26 - - 03/31/26 - - 12/31/25 - - Debt-to-Equity 06/30/26 - - 03/31/26 - 0.00 12/31/25 - 0.00 Debt-to-Capital 06/30/26 - - 03/31/26 - 0.00 12/31/25 - 0.00

Powered by Zacks Investment Research ©